NEW YORK, August 9, 2026, 12:09 EDT — U.S. cash equities shut for Sunday.
- Doximity finished trading on Friday at $27.40, rising 32.6%, and advanced 31.0% over the week.
- Initial estimates indicate the rally boosted market value by roughly $1.2 billion.
- Revenue outlook increased slightly, but the midpoint for adjusted EBITDA declined by $10 million.
Doximity’s preliminary market value rose by roughly $1.2 billion on Friday after its fiscal first-quarter results were released Thursday. At the same time, company leadership lowered the midpoint of its adjusted EBITDA guidance for the full year. Shares ended the session at $27.40, advancing 32.6%.
The disconnect lies in the investor narrative. The midpoint of revenue guidance increased by just $6 million, reaching $676 million. The stock’s rise on Friday represented roughly 200 times this incremental amount. This figure serves as a demonstration of scale, not as a valuation metric.
The data indicates investors factored in AI-driven revenue above the present outlook. Quarterly numbers painted a mixed picture: revenue topped forecasts by 3.2%, while adjusted EPS fell short by a penny.
| Q1 fiscal 2027 metric | Reported | Benchmark | Reading |
|---|---|---|---|
| Revenue | $156.6 million | $151.7 million consensus | Beats by 3.2%; rises 7% |
| Non-GAAP diluted EPS | $0.29 | $0.30 consensus | Falls short by one cent |
| Adjusted EBITDA | $74.8 million | $79.8 million year earlier | Declines 6.3% |
| Free cash flow | $39.6 million | $60.1 million year earlier | Drops 34.1% |
Source: Doximity’s filing and Google Finance consensus data.
CEO Jeff Tangney reported that Doximity achieved “another quarter of record engagement.” The number of workflow active prescribers increased over 30% compared to a year earlier. AI Search queries climbed by more than 25% from the previous quarter. SEC
The increase in usage was accompanied by higher expenditures. Research and development costs were up 44%, reaching $38.5 million. Stock-based compensation increased by 68%, totaling $36.8 million. Non-GAAP gross margin declined by 3.7 percentage points.
On Friday, trading demonstrated both confidence and uncertainty. The stock hit $40 but closed down 31.5% from its peak. A total of 64.9 million shares were traded.
| Asset | Friday move | Week ended August 7 |
|---|---|---|
| Doximity shares | +32.62% | +31.04% |
| Nasdaq Composite | +1.30% | +5.19% |
| S&P 500 | +0.62% | +3.58% |
| Dow Jones Industrial Average | +0.28% | +2.96% |
Source: S&P Global Market Intelligence through StockAnalysis and Reuters.
Doximity surpassed the Nasdaq by almost 26 percentage points over the week, as the S&P 500 reached a new high. The broader market advanced following a disappointing July employment report.
The updated guidance clarifies the AI bet.
| Repricing measure | Prior outlook or close | Updated outlook or close | Change |
|---|---|---|---|
| Fiscal 2027 revenue | $664 million–$676 million | $671 million–$681 million | Midpoint rises $6 million |
| Fiscal 2027 adjusted EBITDA | $323 million–$335 million | $309 million–$329 million | Midpoint falls $10 million |
| Market capitalization, preliminary | About $3.68 billion | $4.88 billion | About $1.20 billion higher |
| Equity gain versus revenue-guide lift | — | About 200 times | — |
The initial market-cap calculation is based on Friday’s disclosed capitalization with the share count remaining the same.
The firm increased its revenue outlook but reduced its adjusted EBITDA guidance for the current year. Despite this, shares surged 32.6%. The market reaction suggests investors saw additional value not captured in the primary forecast.
Analyst updates expanded the spread of forecasts. Google Finance listed eight Buys, 12 Holds and one Sell rating. The mean price target stood at $28.88, representing a 5.4% premium to Friday’s closing price.
| Analyst | Firm | Recommendation | Target | Versus $27.40 |
|---|---|---|---|---|
| Jessica Tassan | Piper Sandler Companies NYSE:PIPR | Buy | $47 | +71.5% |
| Scott Berg | Needham | Buy | $41 | +49.6% |
| Elizabeth Anderson | Evercore Inc. NYSE:EVR | Hold | $40 | +46.0% |
| Brian Peterson | Raymond James Financial, Inc. NYSE:RJF | Buy | $38 | +38.7% |
| Richard Close | Canaccord Genuity Group Inc. (TSE:CF) | Buy | $36 | +31.4% |
| Craig Hettenbach | Morgan Stanley NYSE:MS | Buy | $35 | +27.7% |
| Allen Lutz | Bank of America Corp. NYSE:BAC | Sell | $20 | -27.0% |
Sunday’s Google Finance ratings and targets shown above.
Craig Hettenbach, an analyst at Morgan Stanley, described the latest quarter as “a solid beat” while noting that the guidance was “mixed.” Needham’s Scott Berg increased his price target from $27 to $41. Raymond James also upped its price target, moving to $38 from $23. StockAnalysis
Doximity does not have any corporate events planned for this week. The next item on its investor calendar is the annual meeting on August 27. Meanwhile, investors are focused on the July CPI on Wednesday, PPI on Thursday, and retail sales data on Friday. Those reports have the potential to impact Treasury yields and valuations for growth stocks.
Risks are still pronounced. Canaccord analyst Richard Close noted that AI revenue has “truly yet to hit the P&L.” Pressures from R&D, stock compensation, and free cash flow may continue. Bank of America’s $20 price target suggested a 27% downside. The sharp reversal during Friday trading highlights how quickly expectations can shift. StockAnalysis
Doximity’s valuation currently relies on expectations around AI Search rather than its present earnings performance. The key test ahead is turning usage into revenue. Simply demonstrating usage will not resolve the argument.
Related articles: NYSE:DOCS
